Clinical Imaging
Volume 34, Issue 5 , Pages 348-350 , September 2010

Impact of age on FDG uptake in the liver on PET scan

  • Chun-Yi Lin

      Affiliations

    • Department of Nuclear Medicine, Show Chwan Memorial Hospital, Changhua, Taiwan
    • ,
  • Hueisch-Jy Ding

      Affiliations

    • Department of Medical Imaging and Radiological Sciences, I-Shou University, Kaohsiung, Taiwan
    • ,
  • Cheng-Chieh Lin

      Affiliations

    • Department of Community Medicine and Health Examination Center, China Medical University Hospital, Taichung, Taiwan
    • School of Medicine, China Medical University, Taichung, Taiwan
    • ,
  • Cheng-Chieh Chen

      Affiliations

    • Department of Community Medicine and Health Examination Center, China Medical University Hospital, Taichung, Taiwan
    • ,
  • Shung-Shung Sun

      Affiliations

    • Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung, Taiwan
    • Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan
    • S. S. Sun and C. H. Kao contributed equally to this work.
    • ,
  • Chia-Hung Kao

      Affiliations

    • School of Medicine, China Medical University, Taichung, Taiwan
    • Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Nuclear Medicine and PET Center, China Medical University Hospital, No. 2, Yuh-Der Road, Taichung 404, Taiwan. Tel.: +886 4 22052121x7412; fax.: +886 4 22336174.
    • S. S. Sun and C. H. Kao contributed equally to this work.

Received 20 September 2009 ,Accepted 4 November 2009.

References 

  1. Răileanu I, Rusu V, Stefănescu C, Cinotti L, Hountis D. 18F FDG PET-applications in oncology. Rev Med Chir Soc Med Nat Iasi. 2002;106(1):14–23
  2. Son HB, Han CJ, Kim BI, Kim J, Jeong SH, Kim YC, et al. Evaluation of various hepatic lesions with positron emission tomography. Taehan Kan Hakhoe Chi. 2002;8(4):472–480
  3. Truong MT, Pan T, Erasmus JJ. Pitfalls in integrated CT-PET of the thorax: implications in oncologic imaging. J Thorac Imaging. 2006;21(2):111–122
  4. Gorospe L, Raman S, Echeveste J, Avril N, Herrero Y, Herna Ndez S. Whole-body PET/CT: spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients. Nucl Med Commun. 2005;26(8):671–687
  5. Cook GJ. Pitfalls in PET/CT interpretation. Q J Nucl Med Mol Imaging. 2007;51(3):235–243
  6. Cook GJ, Wegner EA, Fogelman I. Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging. Semin Nucl Med. 2004;34(2):122–133
  7. Lin CY, Ding HJ, Liu CS, Chen YK, Lin CC, Kao CH. Correlation between the intensity of breast FDG uptake and menstrual cycle. Acad Radiol. 2007;14(8):940–944
  8. Vallabhajosula S. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. Semin Nucl Med. 2007;37(6):400–419
  9. Dong MJ, Lin XT, Zhao J, Guan YH, Zuo CT, Chen X, et al. Malignant tumor with false negative 18F-FDG PET image. Zhonghua Zhong Liu Za Zhi. 2006;28(9):713–717
  10. Mahmood S, Martinez de Llano SR. Paget disease of the humerus mimicking metastatic disease in a patient with metastatic malignant mesothelioma on whole body F-18 FDG PET/CT. Clin Nucl Med. 2008;33(7):510–512
  11. Acar C, Akkas BE, Sen I, Sen I, Kitapci MT. False positive 18F-FDG PET scan in adrenal oncocytoma. Urol Int. 2008;80(4):444–447
  12. Roarke MC, Nguyen BD, Pockaj BA. Desmoplastic melanoma: true positive and false negative findings on F-18 FDG-PET/CT. Clin Nucl Med. 2008;33(8):562–564
  13. Thie JA, Hubner KF, Isidoro FP, Smith GT. A weight index for the standardized uptake value in 2-deoxy-2-[F-18]fluoro-d-glucose-positron emission tomography. Mol Imaging Biol. 2007;9(2):91–98
  14. Kitajima K, Murakami K, Yamasaki E, Kaji Y, Sugimura K. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI. Ann Nucl Med. 2008;22(6):505–512
  15. Chin BB, Green ED, Turkington TG, Hawk TC, Coleman RE. Increasing uptake time in FDG-PET: standardized uptake values in normal tissues at 1 versus 3 h. Mol Imaging Biol. 2009;11(2):118–122
  16. Meier JM, Alavi A, Iruvuri S, Alzeair S, Parker R, Houseni M, et al. Assessment of age-related changes in abdominal organ structure and function with computed tomography and positron emission tomography. Semin Nucl Med. 2007;37(3):154–172
  17. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Knowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38(10 Suppl 3):S158–S168
  18. Lu JN, Chen CJ. Prevalence of hepatitis B surface antigen carrier status among residents in the endemic area of chronic arsenicism in Taiwan. Anticancer Res. 1991;11(1):229–233
  19. Craxì A, Laffi G, Zignego AL. Hepatitis C virus (HCV) infection: a systemic disease. Mol Aspects Med. 2008;29(1-2):85–95[Epub 2007 Nov 21]
  20. Sun CA, Chen HC, Lu CF, You SL, Mau YC, Ho MS, et al. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol. 1999;59(3):290–296
  21. Eastman RC, Carson RE, Orloff DG, Cochran CS, Perdue JF, Rechler MM, et al Glucose utilization in a patient with hepatoma and hypoglycemia. Assessment by a positron emission tomography. J Clin Invest. 1992;89(6):1958–1963
  22. Enomoto K, Fukunaga T, Okazumi S, Asano T, Kikuchi T, Yamamoto H, et al Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma. Kaku Igaku. 1991;28(11):1353–1356

PII: S0899-7071(09)00305-2

doi: 10.1016/j.clinimag.2009.11.003

Clinical Imaging
Volume 34, Issue 5 , Pages 348-350 , September 2010

Article Tools